METIS TECHBIO CO LTD-H

Metis Techbio‑H plunges 6% amid biotech volatility—find out why the 200‑day MA drop could signal a rebound, regulatory shifts, and partnership prospects.

Metis Techbio rises 6.62% after announcing a $1 billion partnership with Eli Lilly to develop next‑generation lipid‑nanoparticle drug‑delivery technology.